The identification of NDPACX, an X-linked neurodegenerative disorder manifesting as Parkinsonian syndrome and cognitive impairment in female carriers of SLC9A6 mutations, challenges the conventional dichotomy between neurodevelopmental and neurodegenerative disease paradigms. This evidence concerns the gene SLC9A6 and neurodegenerative disease.